Nitromint (Glyceryl Trinitrate Solution)

Glyceryl trinitrate, the active ingredient in Nitromint, is an organic nitrate vasodilator presented as a sublingual solution for sublingual administration. It acts rapidly to relieve chest pain caused by myocardial ischemia and is employed both for acute treatment of angina pectoris and for prophylactic prevention of angina episodes in adult patients.

GNH USA supplies Nitromint as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including emergency departments and cardiac care units, with full traceability and quality assurance.

Glyceryl trinitrate is employed in cardiovascular care to manage ischemic chest pain by rapidly dilating coronary vessels and reducing cardiac workload.

Acute angina pectoris: provides rapid relief of chest pain during an angina episode. Prophylaxis of angina attacks: reduces frequency of angina episodes when taken before exertion. Chronic stable angina (as part of regimen): improves exercise tolerance and decreases symptom burden. Acute heart failure (off‑label): may be used to lower preload and improve pulmonary congestion in emergency settings.

Glyceryl trinitrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: throbbing pain often occurring shortly after administration. - Flushing: warmth and redness of the face and neck. - Dizziness: sensation of light‑headedness, especially when standing quickly. - Hypotension: drop in blood pressure that may cause faintness.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall leading to syncope. - Syncope: sudden loss of consciousness. - Methemoglobinemia: abnormal hemoglobin that reduces oxygen delivery. - Allergic reaction: rash, itching, swelling, or anaphylaxis.

When using Glyceryl trinitrate, several safety considerations should be observed to minimize risk.

Allergy to nitrates: discontinue immediately if hypersensitivity is identified. Low blood pressure: monitor patients with baseline hypotension to avoid excessive fall. Concurrent PDE‑5 inhibitors: avoid co‑administration due to risk of profound hypotension. Multiple nitrate sources: do not combine with other nitrate medications to prevent additive vasodilation. Store at room temperature: keep in the original container, protect from moisture and light.

Glyceryl trinitrate can interact with other medicines, altering its effect on blood pressure or vascular tone.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause severe hypotension. - Other nitrate preparations (e.g., isosorbide dinitrate): additive vasodilatory effect leading to dangerous blood pressure drop. - Sodium nitroprusside: combined use can result in excessive vasodilation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors, calcium channel blockers): may enhance blood pressure‑lowering effect. - Alcohol: can increase vasodilatory response and dizziness. - Diuretics: may potentiate hypotensive episodes.